Treatment of depression in first episode of schizophrenia: Results from EUFEST-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Treatment of depression in first episode of schizophrenia: Results from EUFEST

Published:2012-12 Issue:12 Volume:22 Page:875-882
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Rybakowski Janusz K.,Vansteelandt Kristof,Szafranski Tomasz,Thys Eric,Jarema Marek,Wolfgang Fleischhacker W.,Kahn René S.,Peuskens Joseph

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Clinical Neurology,Neurology,Pharmacology

Reference55 articles.

1. Assessing depression in schizophrenia: the Calgary depression scale;Addington;Br. J. Psychiatry,1993

2. Specificity of the Calgary scale for schizophrenics;Addington;Schizophr. Res.,1994

3. Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia;Addington;J. Clin. Psychiatry,2011

4. Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology;Barnes;J. Psychopharmacol.,2011

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Melatonergic antidepressant agomelatine: augmentation of antipsychotic drugs in treatment of post-schizophrenic depression;S.S. Korsakov Journal of Neurology and Psychiatry;2024

2. Is depressed mood clinically relevant at the onset of schizophrenia? A longitudinal study.;Archives of Psychiatry and Psychotherapy;2023-06-22

3. Anxious-depressive symptoms after a first episode of schizophrenia: Response to treatment and psychopathological considerations from the 2-year “Parma Early Psychosis” program;Psychiatry Research;2022-11

4. Treatment of post-psychotic depression in first-episode psychosis. A systematic review;Nordic Journal of Psychiatry;2022-05-04

5. Association between depression in chronic phase and future clinical outcome of patients with schizophrenia;Psychopharmacology;2022-02-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3